SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pooled Analysis: Fewer Major Adverse Cardiovascular Events in People with Type 2 Diabetes Treated with Merck Sharp & Dohme's JANUVIA ® (sitagliptin)